| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1994;108:1125-1131
© 1994 Mosby, Inc.
CARDIOPULMONARY BYPASS, |
Osaka, Japan
From the First Department of Surgery, Osaka University Medical School, Osaka, Japan.
Received for publication Dec. 17, 1993. Accepted for publication May 31, 1994. Address for reprints: Hikaru Matsuda, MD, Professor, First Department of Surgery, Osaka University Medical School, 2-2, Yamada-oka, Suita, Osaka 565, Japan.
Abstract
Leukocyte depletion at reperfusion may have a role in myocardial protection when combined with terminal cardioplegia. We applied this method in a selected group of 68 patients with coronary artery bypass grafting either for elective surgical procedures (n= 38) or emergency surgical procedures with the use of a preoperative intraaortic balloon pump (n= 30) because of developing acute myocardial infarction. Basic cold potassium crystalloid cardioplegic solution was used. During delivery of leukocyte-depleted terminal cardioplegic solution, warm arterial blood delivered from cardiopulmonary bypass was passed through a leukocyte removal filter, mixed with potassium crystalloid cardioplegic solution, and administered to the aortic root for the first 10 minutes of reperfusion. Patients were randomized into three groups for reperfusion: whole blood, terminal cardioplegic solution, and leukocyte-depleted terminal cardioplegic solution reperfusion groups. In elective coronary artery bypass grafting, no significant difference was found in the clinical data. However, in emergency coronary artery bypass grafting, the leukocyte-depleted terminal cardioplegic solution group (n= 10) showed significantly lower peak creatine kinase MB levels (leukocyte-depleted terminal cardioplegic solution versus terminal cardioplegic solution versus whole blood: 27 ± 11, 56 ± 13, 74 ± 18, respectively; p< 0.05) and maximum dopamine doses required at the weaning of cardiopulmonary bypass (6.3 ± 1.1 versus 11.2 ± 3.3 versus 9.2 ± 2.2; p< 0.05) than did the terminal cardioplegic solution (n= 10) and whole blood groups (n= 10). Moreover, the leukocyte-depleted terminal cardioplegic solution group showed significantly lower difference of malondialdehyde between arterial and coronary sinus blood (0.15 ± 0.09 versus 0.36 ± 0.06 versus 0.66 ± 0.12 nmol/ml, p< 0.05) than did the terminal cardioplegic solution or whole blood groups. These results showed that leukocyte-depleted terminal blood cardioplegic solution may have a role in attenuating reperfusion injury in patients with critical conditions such as preoperative myocardial ischemic injury. (J THORACCARDIOVASCSURG1994;108:1125-31)
This article has been cited by other articles:
|
|
 |
|
  Y. J. Gu, A. J. de Vries, J. A. M. Hagenaars, and W. van Oeveren Leucocyte filtration of salvaged blood during cardiac surgery: effect on red blood cell function in concentrated blood compared with diluted blood Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 877 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Warren, C. Alexiou, R. Massey, D. Leff, S. Purkayastha, J. Kinross, A. Darzi, and T. Athanasiou The effects of various leukocyte filtration strategies in cardiac surgery Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 665 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Palatianos, G. Balentine, E. G. Papadakis, C. D. Triantafillou, M. I. Vassili, A. Lidoriki, A. Dinopoulos, and G. M. Astras Neutrophil depletion reduces myocardial reperfusion morbidity Ann. Thorac. Surg., March 1, 2004; 77(3): 956 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E M Heerdt, E J Fransen, J G Maessen, and D S de Jong Efficacy of leukocyte depletion of residual pump blood Perfusion, January 1, 2004; 19(1): 3 - 5. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Hayashi, Y. Sawa, N. Fukuyama, Y. Miyamoto, T. Takahashi, H. Nakazawa, and H. Matsuda Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1813 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Chong, C. R. Hampton, and E. D. Verrier Microvascular Inflammatory Response in Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 333 - 354. [Abstract] [PDF]
|
|
|
|
|
|
J. Martin, M. Krause, C. Benk, G. Lutter, M. Siegenthaler, and F. Beyersdorf Blood cardioplegia filtration Perfusion, January 1, 2003; 18(1_suppl): 75 - 80. [Abstract] [PDF]
|
|
|
|
|
|
G. A Ortolano, G. S Aldea, K. Lilly, P. O'Gara, J. D Alkon, F. Madera, T. Murad, C. P Altenbern, C. S Tritt, A. Capetandes, et al. A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of anti-inflammatory effects Perfusion, March 1, 2002; 17(2_suppl): 53 - 62. [Abstract] [PDF]
|
|
|
|
|
|
S J Morris Leukocyte reduction in cardiovascular surgery Perfusion, September 1, 2001; 16(5): 371 - 380. [PDF]
|
|
|
|
|
|
J. P. Gott Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation Perfusion, January 1, 2001; 16(1_suppl): 5 - 9. [Abstract] [PDF]
|
|
|
|
|
|
M. B Patel, K. S Kilgore, G. A Ortolano, C. L Gryboski, M. A Qureshi, P. Marcovitz, K. B Naylor, J. L Park, B. Wenz, N. Gikakis, et al. Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction Perfusion, January 1, 2001; 16(1_suppl): 39 - 49. [Abstract] [PDF]
|
|
|
|
|
|
M. Roth, B. Kraus, T. Scheffold, O. Reuthebuch, W. P. Klovekorn, and E. P. Bauer The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: A randomized, double-blind study J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 642 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Okazaki, Z.-L. Cao, S. Ohtsubo, M. Hamada, K. Naito, K. Rikitake, M. Natsuaki, and T. Itoh Leukocyte-depleted reperfusion after long cardioplegic arrest attenuates ischemia-reperfusion injury of the coronary endothelium and myocardium in rabbit hearts Eur. J. Cardiothorac. Surg., July 1, 2000; 18(1): 90 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hayashi, Y. Sawa, M. Nishimura, H. Ichikawa, K. Kagisaki, S. Ohtake, and H. Matsuda Clinical evaluation of leukocyte-depleted blood cardioplegia for pediatric open heart operation Ann. Thorac. Surg., June 1, 2000; 69(6): 1914 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF]
|
|
|
|
|
|
P G Browning, M Pullan, M Jackson, and A Rashid Leucocyte-depleted cardioplegia does not reduce reperfusion injury in hypothermic coronary artery bypass surgery Perfusion, September 1, 1999; 14(5): 371 - 377. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Kogaki, Y. Sawa, T. Sano, T. Matsushita, T. Ohata, S. Kurotobi, S. J. Tojo, H. Matsuda, and S. Okada Selectin on activated platelets enhances neutrophil endothelial adherence in myocardial reperfusion injury Cardiovasc Res, September 1, 1999; 43(4): 968 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Gu, A.J. de Vries, P. Vos, P. W. Boonstra, and W. van Oeveren Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit Ann. Thorac. Surg., March 1, 1999; 67(3): 604 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Gott, W. A. Cooper, F. E. Schmidt Jr, W. M. Brown III, C. E. Wright, J. D. Merlino, J. D. Fortenberry, W. S. Clark, and R. A. Guyton Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies Ann. Thorac. Surg., September 1, 1998; 66(3): 747 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sawa, H. Ichikawa, K. Kagisaki, T. Ohata, and H. Matsuda Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 511 - 515. [Abstract] [Full Text]
|
|
|
|
|
|
Y. J. Gu, M. A. Mariani, W. van Oeveren, J. G. Grandjean, and P. W. Boonstra Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting Ann. Thorac. Surg., February 1, 1998; 65(2): 420 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A J Heggie, J S Corder, P R Crichton, J W Hesford, H Bingham, S Jeffries, and T L Hooper Clinical evaluation of the new Pall leucocyte-depleting blood cardioplegia filter (BC1) Perfusion, January 1, 1998; 13(1): 17 - 25. [Abstract] [PDF]
|
|
|
|
|
|
Y. Chiba, K. Morioka, R. Muraoka, A. Ihaya, T. Kimura, T. Uesaka, T. Tsuda, and K. Matsuyama Effects of Depletion of Leukocytes and Platelets on Cardiac Dysfunction After Cardiopulmonary Bypass Ann. Thorac. Surg., January 1, 1998; 65(1): 107 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Lazar, X. Zhang, T. Hamasaki, C. A. Memmelo, P. Treanor, S. Rivers, G. S. Aldea, S. A. Bernard, and R. J. Shemin Heparin-Bonded Circuits Decrease Myocardial Ischemic Damage: An Experimental Study Ann. Thorac. Surg., June 1, 1997; 63(6): 1701 - 1705. [Abstract] [Full Text]
|
|
|
|
|
|
M. Roth, E. P. Bauer, O. Reuthebuch, and W. P. Klovekorn SINGLE LEUKOCYTE FILTER (PALL BC1B) FAILS IN MULTIDOSE COLD BLOOD CARDIOPLEGIA J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1116 - 1117. [Full Text]
|
|
|
|
|
|
F. E. Schmidt Jr, M. J. MacDonald, C. O. Murphy, W. M. Brown III, J. P. Gott, and R. A. Guyton Leukocyte Depletion of Blood Cardioplegia Attenuates Reperfusion Injury Ann. Thorac. Surg., December 1, 1996; 62(6): 1691 - 1696. [Abstract] [Full Text]
|
|
|
|
|
|
O. A. R. Binns, N. F. DeLima, S. A. Buchanan, M. C. Mauney, J. T. Cope, S. D. Thies, K. S. Shockey, C. G. Tribble, and I. L. Kron NEUTROPHIL ENDOPEPTIDASE INHIBITOR IMPROVES PULMONARY FUNCTION DURING REPERFUSION AFTER EIGHTEEN-HOUR PRESERVATION J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 607 - 613. [Abstract] [Full Text]
|
|
|
|
|
|
S. Allen Leucocyte depletion in cardiothoracic surgery Perfusion, May 1, 1996; 11(3): 270 - 277. [PDF]
|
|
|
|
 |
|
 Y. Sawa, K. Taniguchi, K. Kadoba, M. Nishimura, H. Ichikawa, A. Amemiya, T. Kuratani, and H. Matsuda Leukocyte Depletion Attenuates Reperfusion Injury in Patients With Left Ventricular Hypertrophy Circulation, May 1, 1996; 93(9): 1640 - 1646. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Sawa, Y. Shimazaki, K. Kadoba, T. Masai, H. Fukuda, T. Ohata, K. Taniguchi, and H. Matsuda ATTENUATION OF CARDIOPULMONARY BYPASS-DERIVED INFLAMMATORY REACTIONS REDUCES MYOCARDIAL REPERFUSION INJURY IN CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 29 - 35. [Abstract] [Full Text]
|
|
|
|
|
|
H. L. Lazar, X. Zhang, T. Hamasaki, P. Treanor, S. Rivers, S. Bernard, and R. J. Shemin Role of Leukocyte Depletion During Cardiopulmonary Bypass and Cardioplegic Arrest Ann. Thorac. Surg., December 1, 1995; 60(6): 1745 - 1748. [Abstract] [Full Text]
|
|
|
|
|
|
F. C. Faes, Y. Sawa, H. Ichikawa, Y. Shimazaki, T. Ohashi, H. Fukuda, R. Shirakura, and H. Matsuda Inhibition of Na+/H+ Exchanger Attenuates Neutrophil-Mediated Reperfusion Injury Ann. Thorac. Surg., August 1, 1995; 60(2): 377 - 381. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
